Adverse musculoskeletal effects of GLP-1 receptor agonists: Focus on semaglutide-induced neck pain
Notably, previous meta-analyses have been inconsistent, and no further meta-analyses have been published in the last 5 years
A meta-analysis of 6 studies 13,20,30,32,33,35 which attempted to estimate overall effect size of the changes from baseline in % FMD following GLP-1-based therapies could not find any significant difference between baseline and end-of-treatment samples (mean change from baseline was 0.83 [1.06, 2.73] %
For research and physician-supervised use only
481,482 (4) A fourth targeted drug approach is the activation of PPAR- in mature adipocytes that then induces altered expression of several genes (increased GLUT4 and adiponectin expression, along with decreased TNF-, IL-6 and leptin expression) involved in the insulin signaling cascade, thereby improving insulin sensitivity